國立虎尾科技大學 |

Atlas of Liquid Biopsy = Circulating Tumor Cells and Other Rare Cells in Cancer Patients’ Blood /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Atlas of Liquid Biopsy/ edited by Ludmilla Thomé Domingos Chinen.
Reminder of title:	Circulating Tumor Cells and Other Rare Cells in Cancer Patients’ Blood /
other author:	Chinen, Ludmilla Thomé Domingos.
Description:	XII, 204 p. 99 illus. in color.online resource. :
Contained By:	Springer Nature eBook
Subject:	Oncology . -
Online resource:	https://doi.org/10.1007/978-3-030-69879-9
ISBN:	9783030698799

Atlas of Liquid Biopsy = Circulating Tumor Cells and Other Rare Cells in Cancer Patients’ Blood /
Atlas of Liquid BiopsyCirculating Tumor Cells and Other Rare Cells in Cancer Patients’ Blood /[electronic resource] :edited by Ludmilla Thomé Domingos Chinen. - 1st ed. 2021. - XII, 204 p. 99 illus. in color.online resource.

Introduction -- Typical Circulating Tumor Cells (CTCs) -- Atypical CTCs -- Endothelial Cells -- Circulating Tumor Microemboli -- Giant Macrophages -- Cells of Undetermined Meaning.

This book provides a wealth of images and extensive information on circulating tumor cells (CTCs) and other cells usually observed in blood from patients with cancer, such as giant macrophages, and circulating tumor microemboli (CTM). The field of “liquid biopsy” began with the analysis of CTCs in the early 2000s. In the beginning, molecular techniques were developed to detect these cells in the blood. However, it has since become clear that CTCs initially require a cytopathological analysis to be detected without false positive and negative results. After detection, molecular analysis can be subsequently performed. Cancer is an important cause of mortality, especially when detected in late stages. Even with all the advances that have been made in its treatment, cancer is still challenging, as many patients do not respond to any therapy. Many health agencies have considered early diagnosis as a feasible tool. In this context, it is of the utmost importance to know the morphology and characteristics of CTCs to determine a correct diagnosis. Currently much of the scientific community is committed to expanding our knowledge of CTCs, and this work makes a valuable contribution, presenting many cell images from patients with several types of cancer, in different stages of disease, and after receiving various treatments. The Atlas of Liquid Biopsy: Circulating Tumor Cells and Other Rare Cells in Cancer Patients’ Blood is an essential reference guide for all physicians, biologists, biomedics, and professionals working at hospitals, clinics and research centers.

ISBN: 9783030698799

Standard No.: 10.1007/978-3-030-69879-9doiSubjects--Topical Terms:

1253469
Oncology .

LC Class. No.: RC254-282

Dewey Class. No.: 616.994

Atlas of Liquid Biopsy = Circulating Tumor Cells and Other Rare Cells in Cancer Patients’ Blood /
LDR:03104nam a22003855i 4500 001 1055033
003 DE-He213
005 20210819051910.0
007 cr nn 008mamaa
008 220103s2021 sz | s |||| 0|eng d
020 $a 9783030698799 $9 978-3-030-69879-9
024 7 $a 10.1007/978-3-030-69879-9 $2 doi
035 $a 978-3-030-69879-9
050 4 $a RC254-282
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994 $2 23
245 1 0 $a Atlas of Liquid Biopsy $h [electronic resource] : $b Circulating Tumor Cells and Other Rare Cells in Cancer Patients’ Blood / $c edited by Ludmilla Thomé Domingos Chinen.
250 $a 1st ed. 2021.
264 1 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2021.
300 $a XII, 204 p. 99 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
505 0 $a Introduction -- Typical Circulating Tumor Cells (CTCs) -- Atypical CTCs -- Endothelial Cells -- Circulating Tumor Microemboli -- Giant Macrophages -- Cells of Undetermined Meaning.
520 $a This book provides a wealth of images and extensive information on circulating tumor cells (CTCs) and other cells usually observed in blood from patients with cancer, such as giant macrophages, and circulating tumor microemboli (CTM). The field of “liquid biopsy” began with the analysis of CTCs in the early 2000s. In the beginning, molecular techniques were developed to detect these cells in the blood. However, it has since become clear that CTCs initially require a cytopathological analysis to be detected without false positive and negative results. After detection, molecular analysis can be subsequently performed. Cancer is an important cause of mortality, especially when detected in late stages. Even with all the advances that have been made in its treatment, cancer is still challenging, as many patients do not respond to any therapy. Many health agencies have considered early diagnosis as a feasible tool. In this context, it is of the utmost importance to know the morphology and characteristics of CTCs to determine a correct diagnosis. Currently much of the scientific community is committed to expanding our knowledge of CTCs, and this work makes a valuable contribution, presenting many cell images from patients with several types of cancer, in different stages of disease, and after receiving various treatments. The Atlas of Liquid Biopsy: Circulating Tumor Cells and Other Rare Cells in Cancer Patients’ Blood is an essential reference guide for all physicians, biologists, biomedics, and professionals working at hospitals, clinics and research centers.
650 0 $a Oncology . $3 1253469
650 0 $a Pathology. $3 668553
650 1 4 $a Oncology. $3 593951
700 1 $a Chinen, Ludmilla Thomé Domingos. $e editor. $4 edt $4 http://id.loc.gov/vocabulary/relators/edt $3 1360190
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783030698782
776 0 8 $i Printed edition: $z 9783030698805
856 4 0 $u https://doi.org/10.1007/978-3-030-69879-9
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)